Volume 71, Issue 1, Pages (January 2017)

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 2009)
Advertisements

Volume 55, Issue 1, Pages 1-8 (January 2009)
Volume 72, Issue 1, Pages (July 2017)
Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit  Pim J. van Leeuwen, David Connolly, Anna.
Volume 59, Issue 2, Pages (February 2011)
Volume 68, Issue 2, Pages (August 2015)
Volume 62, Issue 1, Pages (July 2012)
Volume 51, Issue 2, Pages (February 2007)
Volume 62, Issue 5, Pages (November 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
European Urology Focus
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 61, Issue 6, Pages (June 2012)
Volume 67, Issue 1, Pages (January 2015)
Volume 53, Issue 4, Pages (April 2008)
Volume 64, Issue 6, Pages (December 2013)
Volume 68, Issue 5, Pages (November 2015)
Volume 67, Issue 4, Pages (April 2015)
Volume 73, Issue 6, Pages (June 2018)
Volume 64, Issue 4, Pages (October 2013)
Volume 70, Issue 4, Pages (October 2016)
Volume 71, Issue 5, Pages (May 2017)
Prostate Cancer Epidemic in Sight?
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Volume 68, Issue 5, Pages (November 2015)
Prostate Cancer Detection: A View of the Future
Volume 54, Issue 5, Pages (November 2008)
Volume 184, Issue 4, Pages (October 2010)
Volume 67, Issue 3, Pages (March 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 3, Pages (March 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Volume 66, Issue 3, Pages (September 2014)
Volume 62, Issue 1, Pages (July 2012)
Volume 66, Issue 6, Pages (December 2014)
Prostate Cancer Epidemic in Sight?
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 68, Issue 6, Pages (December 2015)
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 4, Pages (April 2008)
Volume 63, Issue 3, Pages (March 2013)
Volume 62, Issue 4, Pages (October 2012)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Volume 50, Issue 5, Pages (November 2006)
Volume 58, Issue 3, Pages (September 2010)
Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 59, Issue 4, Pages (April 2011)
Volume 72, Issue 1, Pages (July 2017)
European Urology is “Your” Journal
Thomas Steuber, Matthew Frank O'Brien, Hans Lilja  European Urology 
Epidemiology of Renal Cell Carcinoma
European Urology Oncology
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 68, Issue 2, Pages (August 2015)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 2, Pages (February 2007)
Does PSA Testing Influence the Natural History of Prostate Cancer?
Volume 51, Issue 5, Pages (May 2007)
Volume 76, Issue 1, Pages (July 2019)
Presentation transcript:

Volume 71, Issue 1, Pages 46-52 (January 2017) Screening for Prostate Cancer Starting at Age 50–54 Years. A Population-based Cohort Study  Sigrid Carlsson, Melissa Assel, David Ulmert, Axel Gerdtsson, Jonas Hugosson, Andrew Vickers, Hans Lilja  European Urology  Volume 71, Issue 1, Pages 46-52 (January 2017) DOI: 10.1016/j.eururo.2016.03.026 Copyright © 2016 Terms and Conditions

Fig. 1 Cumulative risk of prostate cancer diagnosis. European Urology 2017 71, 46-52DOI: (10.1016/j.eururo.2016.03.026) Copyright © 2016 Terms and Conditions

Fig. 2 Cumulative risk of prostate cancer metastasis. European Urology 2017 71, 46-52DOI: (10.1016/j.eururo.2016.03.026) Copyright © 2016 Terms and Conditions

Fig. 3 Cumulative risk of prostate cancer death. European Urology 2017 71, 46-52DOI: (10.1016/j.eururo.2016.03.026) Copyright © 2016 Terms and Conditions

Fig. 4 Cumulative risk of overall mortality. European Urology 2017 71, 46-52DOI: (10.1016/j.eururo.2016.03.026) Copyright © 2016 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.